Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.

Area of Science:

• Pharmacology
• Bioinformatics
• Computational Biology

Background:

• The escalating costs of novel drug development necessitate innovative strategies.
• Drug repositioning, or identifying new therapeutic uses for existing drugs, offers a cost-effective alternative.
• Machine learning (ML) presents a powerful computational approach to facilitate drug repositioning.

Purpose of the Study:

• To provide an overview of ML principles and algorithms applicable to drug repositioning.
• To discuss methods for evaluating the predictive performance of ML models in this context.
• To highlight challenges and resources relevant to ML-driven drug repurposing using gene expression data.

Main Methods:

• Review of general principles and various types of ML algorithms.
• Discussion of common approaches for evaluating predictive performance.
• Focus on the application of ML to predict drug repurposing opportunities utilizing drug expression data.

Main Results:

• ML algorithms can effectively identify patterns in biological data to predict drug repurposing potential.
• Gene expression data serves as a valuable feature set for these predictive models.
• Common issues and caveats in applying ML for drug repositioning are identified.

Conclusions:

• ML-driven drug repositioning, particularly using gene expression data, is a promising strategy to accelerate the discovery of new therapeutic indications.
• Understanding ML methodologies and potential pitfalls is crucial for successful implementation.
• Availability of drug expression data resources supports the advancement of this approach.